Cytarabine (Pf) (cytarabine/PF)

Advertisement

Last reviewed · Source: First Databank (FDB) drug data

Overview

USES: Cytarabine is used to treat various types of cancer. It is a chemotherapy drug that works by slowing or stopping cancer cell growth.

Generic name: cytarabine/PF
Pronunciation: (sye-TAIR-uh-bean)

Reference product & biosimilars

No reference, biosimilar or interchangeable associated with this drug.

Today’s intelligence on Cytarabine (Pf)

Intelligence content is not available yet.

Indications

The following indications are listed for Cytarabine (Pf):

  • Acute Lymphoid Leukemia
  • Acute Myeloid Leukemia
  • Acute Promyelocytic Leukemia
  • Blastic Phase Chronic Myeloid Leukemia
  • Meningeal Leukemia

Also known as: Acute Granulocytic Leukemia, Acute Leukemic Myelosis, Acute Lymphatic Leukemia, Acute Lymphocytic Leukemia, Acute Lymphogenous Leukemia, Acute Myelocytic Leukemia, Acute Myelogenic Leukemia, Acute Myelogenous Leukemia, Acute Non-Lymphoblastic Leukemia, Acute Non-Lymphocytic Leukemia, Chronic Granulocytic Leukemia In Blast Crisis Phase, Chronic Leukemic Myelosis, Blast Crisis Phase, Chronic Myelogenic Leukemia In Blast Crisis Phase, Chronic Myelogenous Leukemia In Blast Crisis Phase, Chronic Myeloid Leukemia In Blast Crisis Phase, Cml Blast Crisis Phase, Leukemic Leptomeningitis, Leukemic Meningitis, Lymphoblastic Leukemia, Promyelocytic Leukemia.

Dosing

No dosing information is available for this tab.

Drug interactions

There is no enhanced messaging for this drug.

Contraindications

There is no enhanced messaging for this drug.

Adverse reactions

There is no enhanced messaging for this drug.

Precautions

No enhanced messaging available.

ICD codes

No ICD codes are available for this drug.

Formulary status

Search health-plan coverage for this drug by ZIP code.

Enter a ZIP code to view available health plans.

Last reviewed · Source: First Databank (FDB) drug data